Botulism Therapeutics Market Pipeline Review, H2 2017
“Pharmaceutical and Healthcare disease pipeline guide Botulism - Pipeline
Review, H2 2017, provides an overview of the Botulism (Infectious Disease)
pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Botulism - Pipeline Review, H2 2017, provides an
overview of the Botulism (Infectious Disease) pipeline landscape.
Botulism is a rare but serious illness. The cause is a toxin (poison) made by a bacterium called Clostridium
botulinum. It occurs naturally in soil. Food borne botulism comes from eating foods contaminated with the
toxin. Symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing, dry
mouth, and muscle weakness. Treatment may include antitoxins, intensive medical care, or surgery of infected
wounds.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Botulism - Pipeline Review, H2 2017, provides
comprehensive information on the therapeutics under development for Botulism (Infectious Disease),
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
Browse Detail Report With TOC @
http://www.hexareports.com/report/botulism-pipeline-review-h2-2017
Follow Us: